{
  "symbol": "TGT",
  "year": 2022,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.2052,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.094
  },
  "top_positive": [
    {
      "sent": "TARGET CORPORATION Q3 2022 Form 10-Q 4 FINANCIAL STATEMENTS Table of Contents Index to Notes Consolidated Statements of Shareholders\u2019 Investment Common Stock Additional Accumulated Other Stock Par Paid-in Retained Comprehensive (millions)\u00a0(unaudited) Shares Value Capital Earnings (Loss) / Income Total January 30, 2021 500.9 $ 42 $ 6,329 $ 8,825 $ ( 756 ) $ 14,440 Net earnings \u2014 \u2014 \u2014 2,097 \u2014 2,097 Other comprehensive income \u2014 \u2014 \u2014 \u2014 31 31 Dividends declared \u2014 \u2014 \u2014 ( 343 ) \u2014 ( 343 ) Repurchase of stock ( 6.1 ) ( 1 ) \u2014 ( 1,207 ) \u2014 ( 1,208 ) Stock options and awards 1.3 \u2014 ( 58 ) \u2014 \u2014 ( 58 ) May 1, 2021 496.1 $ 41 $ 6,271 $ 9,372 $ ( 725 ) $ 14,959 Net earnings \u2014 \u2014 \u2014 1,817 \u2014 1,817 Other comprehensive income \u2014 \u2014 \u2014 \u2014 12 12 Dividends declared \u2014 \u2014 \u2014 ( 445 ) \u2014 ( 445 ) Repurchase of stock ( 6.6 ) \u2014 \u2014 ( 1,544 ) \u2014 ( 1,544 ) Stock options and awards 0.2 \u2014 61 \u2014 \u2014 61 July 31, 2021 489.7 $ 41 $ 6,332 $ 9,200 $ ( 713 ) $ 14,860 Net earnings \u2014 \u2014 \u2014 1,488 \u2014 1,488 Other comprehensive income \u2014 \u2014 \u2014 \u2014 26 26 Dividends declared \u2014 \u2014 \u2014 ( 439 ) \u2014 ( 439 ) Repurchase of stock ( 8.8 ) ( 1 ) \u2014 ( 2,180 ) \u2014 ( 2,181 ) Stock options and awards \u2014 \u2014 49 \u2014 \u2014 49 October 30, 2021 480.9 $ 40 $ 6,381 $ 8,069 $ ( 687 ) $ 13,803 Net earnings \u2014 \u2014 \u2014 1,544 \u2014 1,544 Other comprehensive income \u2014 \u2014 \u2014 \u2014 134 134 Dividends declared \u2014 \u2014 \u2014 ( 428 ) \u2014 ( 428 ) Repurchase of stock ( 9.8 ) ( 1 ) \u2014 ( 2,265 ) \u2014 ( 2,266 ) Stock options and awards 0.2 \u2014 40 \u2014 \u2014 40 January 29, 2022 471.3 $ 39 $ 6,421 $ 6,920 $ ( 553 ) $ 12,827 TARGET CORPORATION Q3 2022 Form 10-Q 5 FINANCIAL STATEMENTS Table of Contents Index to Notes Consolidated Statements of Shareholders\u2019 Investment Common Stock Additional Accumulated Other Stock Par Paid-in Retained Comprehensive (millions)\u00a0(unaudited) Shares Value Capital Earnings (Loss) / Income Total January 29, 2022 471.3 $ 39 $ 6,421 $ 6,920 $ ( 553 ) $ 12,827 Net earnings \u2014 \u2014 \u2014 1,009 \u2014 1,009 Other comprehensive income \u2014 \u2014 \u2014 \u2014 201 201 Dividends declared \u2014 \u2014 \u2014 ( 426 ) \u2014 ( 426 ) Repur\n decrease are described on page 21 .",
      "score": 0.9825
    },
    {
      "sent": "Reconciliation of Non-GAAP Adjusted EPS Three Months Ended October 29, 2022 October 30, 2021 (millions, except per share data) Pretax Net of Tax Per Share Pretax Net of Tax Per Share GAAP diluted earnings per share $ 1.54 $ 3.04 Adjustments Other (a) $ \u2014 $ \u2014 $ \u2014 $ (9) $ (7) $ (0.01) Adjusted diluted earnings per share $ 1.54 $ 3.03 Reconciliation of Non-GAAP Adjusted EPS Nine Months Ended October 29, 2022 October 30, 2021 (millions, except per share data) Pretax Net of Tax Per Share Pretax Net of Tax Per Share GAAP diluted earnings per share $ 4.09 $ 10.87 Adjustments Gain on Dermstore sale $ \u2014 $ \u2014 $ \u2014 $ (335) $ (269) $ (0.54) Other (a) 20 15 0.03 27 20 0.04 Adjusted diluted earnings per share $ 4.12 $ 10.37 Note: Amounts may not foot due to rounding.",
      "score": 0.9657
    },
    {
      "sent": "TARGET CORPORATION Q3 2022 Form 10-Q 20 MANAGEMENT'S DISCUSSION AND ANALYSIS Table of Contents ANALYSIS OF FINANCIAL CONDITION Index to Notes Analysis of Financial Condition Liquidity and Capital Resources Capital Allocation We follow a disciplined and balanced approach to capital allocation based on the following priorities, ranked in order of importance: first, we fully invest in opportunities to profitably grow our business, create sustainable long-term value, and maintain our current operations and assets; second, we maintain a competitive quarterly dividend and seek to grow it annually; and finally, we return any excess cash to shareholders by repurchasing shares within the limits of our credit rating goals.",
      "score": 0.949
    }
  ],
  "top_negative": [
    {
      "sent": "Quantitative and Qualitative Disclosures About Market Risk There have been no material changes in our primary risk exposures or management of market risks from those disclosed in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk of our Form\u00a010-K for the fiscal year ended January\u00a029, 2022.",
      "score": -0.8225
    },
    {
      "sent": "Quantitative and Qualitative Disclosures About Market Risk There have been no material changes in our primary risk exposures or management of market risks from those disclosed in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk of our Form\u00a010-K for the fiscal year ended January\u00a029, 2022.",
      "score": -0.8225
    },
    {
      "sent": "TARGET CORPORATION Q3 2022 Form 10-Q 3 FINANCIAL STATEMENTS Table of Contents Index to Notes Consolidated Statements of Cash Flows Nine Months Ended (millions)\u00a0(unaudited) October 29, 2022 October 30, 2021 Operating activities Net earnings $ 1,904 $ 5,402 Adjustments to reconcile net earnings to cash provided by operating activities: Depreciation and amortization 2,004 1,952 Share-based compensation expense 177 187 Deferred income taxes 548 233 Gain on Dermstore sale \u2014 ( 335 ) Noncash losses / (gains) and other, net 141 18 Changes in operating accounts: Inventory ( 3,215 ) ( 4,305 ) Other assets ( 205 ) ( 117 ) Accounts payable ( 224 ) 3,284 Accrued and other liabilities ( 578 ) ( 722 ) Cash provided by operating activities 552 5,597 Investing activities Expenditures for property and equipment ( 4,323 ) ( 2,483 ) Proceeds from disposal of property and equipment 4 23 Proceeds from Dermstore sale \u2014 356 Other investments 16 14 Cash required for investing activities ( 4,303 ) ( 2,090 ) Financing activities Change in commercial paper, net 2,104 \u2014 Additions to long-term debt 991 \u2014 Reductions of long-term debt ( 139 ) ( 112 ) Dividends paid ( 1,339 ) ( 1,116 ) Repurchase of stock ( 2,825 ) ( 5,042 ) Stock option exercises 2 5 Cash required for financing activities ( 1,206 ) ( 6,265 ) Net decrease in cash and cash equivalents ( 4,957 ) ( 2,758 ) Cash and cash equivalents at beginning of period 5,911 8,511 Cash and cash equivalents at end of period $ 954 $ 5,753 Supplemental information Leased assets obtained in exchange for new finance lease liabilities $ 116 $ 234 Leased assets obtained in exchange for new operating lease liabilities 203 482 See accompanying Notes to Consolidated Financial Statements .",
      "score": -0.7964
    }
  ],
  "forward_snippets": [
    "We report after-tax return on invested capital (ROIC) because we believe ROIC provides a meaningful measure of our capital allocation effectiveness over time.",
    "We believe this is consistent with the broader industry trends.",
    "We believe that the actions we have taken reduce our risks and provide additional flexibility to focus on serving guests in a rapidly changing environment.",
    "We expect that comparable sales growth will drive the majority of our total sales growth.",
    "We believe that our ability to successfully differentiate our guests\u2019 shopping experience through a careful combination of merchandise assortment, price, convenience, guest experience, and other factors will, over the long-term, drive both increasing shopping frequency (traffic) and the amount spent each visit (average transaction amount)."
  ]
}